No Controversy Here

While controversy exists in the USA concerning research with embryonic stem cells, everyone agrees that using adult stem cells are appropriate and efficacious. Rabin Medical Center has made a major breakthrough in applying adult stem cells to treat Parkinson's disease by developing NurOwn, a technology that generates neuron-like cells derived from human bone marrow. Using the patient's own bone marrow to supply dopamineproducing cells circumvents problems of immunity and compatibility. Credit for the discovery goes to Prof. Eldad Melamed, Director of Neurology at the Rabin Medical Center and member of the Michael J. Fox Foundation for Parkinson's Research, together with Dr. Daniel Offen, Director of Laboratory of Neurosciences at Rabin Medical Center, and Dr. Yosef Levy. Commercialized by Brainstorm Cell Therapeutics based in Tel Aviv, NurOwn actually produces the missing chemical that enables restoration of motor movement.

Related Articles

Coca-Cola 'the Real Deal' for Gastrointestinal Clogs


Greek study discovers benefits of carbonated beverage, shows drink can open up clogs in people with convoluted systems.


read more »

Kidney Transplant Breakthrough Saves Lives


Kidneys are the most commonly transplanted organs in the US and in Israel, but there is still a huge shortage of available organs.


read more »

Heart Surgeries Televised Globally


The prestigious Division of Cardiology at Rabin Medical Center, headed by Prof. Alexander Battler, is the leading facility for heart patients in Israel.


read more »